Exact Mass: 321.2031

Phenazocine, (-)-

C22H27NO (321.2093)

D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids N - Nervous system > N02 - Analgesics > N02A - Opioids > N02AD - Benzomorphan derivatives D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics

Phenazocine

C22H27NO (321.2093)

Croomine

C18H27NO4 (321.194)

A natural product found particularly in Stemona tuberosa and Stemona phyllantha.

7-Angeloyl-9-(2-methylbutyryl)heliotridine

C18H27NO4 (321.194)

omega-Hydroxycapsaicin

C18H27NO4 (321.194)

Lycoposerramine N

C18H27NO4 (321.194)

CFA-L-isoleucine

C18H27NO4 (321.194)

(-)3alpha-6beta-ditigloyloxytropane

C18H27NO4 (321.194)

C18H27NO4

C18H27NO4 (321.194)

SCHEMBL4581440

C18H27NO4 (321.194)

dubiusamine-B

C18H27NO4 (321.194)

8beta-acetoxyfawcettimine

C18H27NO4 (321.194)

(5beta,15R)-15-hydroxy-15-methyl-8-oxolycopodan-5-yl acetate|obscurumine G

C18H27NO4 (321.194)

8beta-acetoxy-12beta-hydroxylycopodine

C18H27NO4 (321.194)

8beta-hydroxy-11alpha-acetoxylycopodine

C18H27NO4 (321.194)

FT-0669336

C18H27NO4 (321.194)

N-Feruloylspermidine

C17H27N3O3 (321.2052)

3-hydroxy-N-(1-hydroxy-4-methylpentan-2-yl)-5-oxo-6-phenylhexanamide

C18H27NO4 (321.194)

3-hydroxy-N-(1-hydroxy-4-methylpentan-2-yl)-5-oxo-6-phenylhexanamide [IIN-based on: CCMSLIB00000849085]

C18H27NO4 (321.194)

3-hydroxy-N-(1-hydroxy-4-methylpentan-2-yl)-5-oxo-6-phenylhexanamide [IIN-based: Match]

C18H27NO4 (321.194)

N-coronafacoyl-L-isoleucine

C18H27NO4 (321.194)

3-Hydroxy-N-(1-hydroxy-4-methyl-2-pentanyl)-5-oxo-6-phenylhexanamide

C18H27NO4 (321.194)

N-(3S,4S-methylene-decanoyl) histidine

C17H27N3O3 (321.2052)

Tetrabutylammonium bromide

C16H36BrN (321.2031)

D013501 - Surface-Active Agents > D003902 - Detergents

BOC-L-4-tBu-phe

C18H27NO4 (321.194)

Ethybenztropine

C22H27NO (321.2093)

N - Nervous system > N04 - Anti-parkinson drugs > N04A - Anticholinergic agents > N04AC - Ethers of tropine or tropine derivatives C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent

azane,1-ethoxybutane,furan-2,5-dione,styrene

C18H27NO4 (321.194)

9-(6-methoxynaphthalen-2-yl)-3-methyl-3-azaspiro[5.5]undec-9-ene

C22H27NO (321.2093)

Sequifenadine

C22H27NO (321.2093)

R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist

4-BROMO-3,5-DIHYDROXYBENZAMIDE

C14H31NO5Si (321.1971)

2-(1,1-diethoxyethyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

C17H28BNO4 (321.2111)

N-Hexyl-N,N-dimethyl-1-octanaminium bromide

C16H36BrN (321.2031)

4-Nitrophenyl Laurate

C18H27NO4 (321.194)

etoxeridine

C18H27NO4 (321.194)

C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent

4-(1-Pyrazin-2-yl-ethoxyMethyl)-piperidine-1-carboxylic acid tert-butyl ester

C17H27N3O3 (321.2052)

N-Ethyl-N,N-dimethyl-1-dodecanaminium bromide

C16H36BrN (321.2031)

Boc-D-4-tert-Butylphenylalanine

C18H27NO4 (321.194)

(+)-Phenazocine

C22H27NO (321.2093)

D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids N - Nervous system > N02 - Analgesics > N02A - Opioids > N02AD - Benzomorphan derivatives D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics

monacolin L carboxylate

C19H29O4- (321.2066)

A hydroxy monocarboxylic acid anion that is the conjugate base of monacolin L acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

Chloroquine dication

C18H28ClN3+2 (321.1972)

17-Hydroxy-1-oxo-2,3-secoandrostan-3-oate

C19H29O4- (321.2066)

3-hydroxy-N-(1-hydroxy-4-methylpentan-2-yl)-5-oxo-6-phenylhexanamide

C18H27NO4 (321.194)

(5S,6R,9R)-14-amino-5-methoxy-3,6,9-trimethyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-2-one

C17H27N3O3 (321.2052)

2-Hexyl-5-(7-carboxyheptyl)resorcinol

C19H29O4- (321.2066)

Bicarphene hydrochloride

C22H27NO (321.2093)

Phenazocine, (-)-

C22H27NO (321.2093)

D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids N - Nervous system > N02 - Analgesics > N02A - Opioids > N02AD - Benzomorphan derivatives D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics

NA-Taurine 13:0

C15H31NO4S (321.1974)

NA-Tyr 9:0

C18H27NO4 (321.194)

VU0080241

C19H23N5 (321.1953)

VU0080241 is a positive allosteric modulator (PAM) of the metabotropic glutamate receptor subtype 4 (mGluR4), with an EC50 of 4.6 μM[1].

(1s,2s,3s,10s,13s,15r)-2-hydroxy-15-methyl-11-oxo-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-3-yl acetate

C18H27NO4 (321.194)

7-angeloyl-9-(2-methylbutyryl)heliotridine

C18H27NO4 (321.194)

{"Ingredient_id": "HBIN013050","Ingredient_name": "7-angeloyl-9-(2-methylbutyryl)heliotridine","Alias": "NA","Ingredient_formula": "C18H27NO4","Ingredient_Smile": "CCC(C)C(=O)OCC1=CCN2C1C(CC2)OC(=O)C(=CC)C","Ingredient_weight": "321.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "37196","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "91748012","DrugBank_id": "NA"}

2-hydroxy-15-methyl-11-oxo-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-3-yl acetate

C18H27NO4 (321.194)

(1s,7ar)-7-({[(2r)-2-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl (2z)-2-methylbut-2-enoate

C18H27NO4 (321.194)

8-methyl-3-[(2-methylbut-2-enoyl)oxy]-8-azabicyclo[3.2.1]octan-6-yl 2-methylbut-2-enoate

C18H27NO4 (321.194)

4-methyl-3'-(4-methyl-5-oxooxolan-2-yl)-octahydrospiro[oxolane-2,9'-pyrrolo[1,2-a]azepin]-5-one

C18H27NO4 (321.194)

(2r,3s)-2-({[(3as,6r,7as)-6-ethyl-1-oxo-2,3,3a,6,7,7a-hexahydroinden-4-yl](hydroxy)methylidene}amino)-3-methylpentanoic acid

C18H27NO4 (321.194)

(2r,3's,4r,9'ar)-4-methyl-3'-[(2s,4s)-4-methyl-5-oxooxolan-2-yl]-octahydrospiro[oxolane-2,9'-pyrrolo[1,2-a]azepin]-5-one

C18H27NO4 (321.194)

(1s,2s,4s,5s,6s,9s)-2-hydroxy-4-methyl-8-oxo-13-azatetracyclo[7.7.0.0¹,⁶.0²,¹³]hexadecan-5-yl acetate

C18H27NO4 (321.194)

(1s,2s,4s,5r,6s,9s)-2-hydroxy-4-methyl-8-oxo-13-azatetracyclo[7.7.0.0¹,⁶.0²,¹³]hexadecan-5-yl acetate

C18H27NO4 (321.194)

(1r,3r,5s,6r)-8-methyl-3-{[(2e)-2-methylbut-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-6-yl (2e)-2-methylbut-2-enoate

C18H27NO4 (321.194)

9-hydroxy-n-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enimidic acid

C18H27NO4 (321.194)

(1s,3r,5r,6s)-8-methyl-3-{[(2e)-2-methylbut-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-6-yl (2e)-2-methylbut-2-enoate

C18H27NO4 (321.194)

2-{[(6-ethyl-1-oxo-2,3,3a,6,7,7a-hexahydroinden-4-yl)(hydroxy)methylidene]amino}-3-methylpentanoic acid

C18H27NO4 (321.194)

(2r,3r)-2-({[(3as,6r,7as)-6-ethyl-1-oxo-2,3,3a,6,7,7a-hexahydroinden-4-yl](hydroxy)methylidene}amino)-3-methylpentanoic acid

C18H27NO4 (321.194)

(6e,8r)-9-hydroxy-n-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enimidic acid

C18H27NO4 (321.194)

(5r)-3-methyl-5-[(2r)-1-{4-[(2r,4r)-4-methyl-5-oxooxolan-2-yl]butyl}pyrrolidin-2-yl]-5h-furan-2-one

C18H27NO4 (321.194)

(6e,8s)-9-hydroxy-n-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enimidic acid

C18H27NO4 (321.194)

3-methyl-5-{1-[4-(4-methyl-5-oxooxolan-2-yl)butyl]pyrrolidin-2-yl}-5h-furan-2-one

C18H27NO4 (321.194)

7-{[(2-methylbutanoyl)oxy]methyl}-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl 2-methylbut-2-enoate

C18H27NO4 (321.194)